Scleroderma Is a broad term encompassing both localized and systemic sclerosis. Localized
scleroderma is a cutaneous limited fibrosis that manifests as plaque morphea, generalized …

Extracorporeal phototherapy (ECP) is a therapeutic approach based on the biological effect
of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA) on mononuclear cells …

Scleroderma, a chronic, progressive disorder, is characterized by dermal fibrosis with
collagen bundles orientated parallel to the epidermis. Simple objective parameters to …

Extracorporeal photopheresis (ECP) is a well‐tolerated procedure that suppresses T‐
lymphocyte activity in a clonally‐specific way. It is an effective therapy that has established …

Connective‐tissue disorders, which include lupus erythematosus, morphoea/scleroderma
and dermatomyositis, are characterized by cutaneous manifestations that are sometimes …

Abstract Systemic sclerosis (scleroderma)(SSc) is a rare autoimmune disorder characterized
by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy …

Background Eosinophilic fasciitis (EF) is a rare connective tissue disorder characterized
clinically by symmetrical swelling, induration and thickening of the skin and histologically by …

Objectives To investigate the reliability of durometry in systemic sclerosis (SSc), by means of
a systematic review and additional pilot study. Methods Literature was systematically …

Photopheresis is a form of phototherapy where specialized equipment is used to isolate a
leukocyte fraction from the peripheral blood which is then exposed to photoactivated 8 …

Current drug therapy for scleroderma and secondary Raynaud's... : Current Opinion in
Rheumatology Current drug therapy for scleroderma and secondary Raynaud's …